UBS Group’s St Jude Medical STJ Stock Holding History

UBS Group’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-13,814	Closed	-$853K	–	8624
2015 Q4	$853K	Hold	13,814	–	–	﹤0.01%	3536
2015 Q3	$872K	Buy	13,814 +13,014	+1,627%	+$929K	﹤0.01%	3476
2015 Q2	$58K	Sell	800 -14,566	-95%	-$1.05M	﹤0.01%	5878
2015 Q1	$1M	Sell	15,366 -3,006	-16%	-$200K	﹤0.01%	3576
2014 Q4	$1.2M	Buy	+18,372	New	+$1.18M	﹤0.01%	3423

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

UBS Group's STJ Position: Q1 2017 in Review

UBS Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,343,476 shares — an estimated $108M sold.

UBS Group first reported a position in STJ in Q4 2014 and held it in 9 quarters. The position peaked at $178M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

UBS Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
UBS Group sold 1,343,476 St Jude Medical shares in Q1 2017, an estimated $108M.
UBS Group first reported a position in St Jude Medical in Q4 2014 and held it in 9 quarters.
UBS Group's St Jude Medical position peaked at $178M in Q2 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.